ストックスクリーナーアプリを入手
3.62
3.43%
0.12
プレマーケット:
3.70
0.08
+2.21%
Ardelyx Inc (ARDX) 最新ニュース
Investors in Ardelyx, Inc. (ARDX): Protect Your RightsContact Levi & Korsinsky Before November 16, 2026 - accessnewswire.com
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Ardelyx, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.
Bronstein, Gewirtz & Grossman LLC Urges Ardelyx, Inc. Investors to Act: Class Action Filed Alleging Investor Harm - PR Newswire
Rosen Law Firm Urges Ardelyx, Inc. (NASDAQ: ARDX) Stockholders with Large Losses to Contact the Firm for Information About Their Rights - Business Wire
Ardelyx puts lessons from FDA’s Untitled Letters into practice in first Ibsrela TV campaign - Medical Marketing and Media
Class action filed against Ardelyx over misleading growth claims, stock drops 18% after revenue guidance cut. - Pluang
Investors in Ardelyx face lawsuit over alleged misleading revenue guidance and stock drop. - Pluang
Class action lawsuit filed against Ardelyx over misleading statements on drug sales and patient access. - Pluang
ARDX Investors Have Opportunity to Lead Ardelyx, Inc. Securities Fraud Lawsuit - PR Newswire
Ardelyx Targets $500M Revenue This Year, Profitability by 2027 - TradingView
Investor Alert: Robbins LLP Informs Investors of the Ardelyx, Inc. Class Action Lawsuit - The National Law Review
Ardelyx (ARDX) Stock Still Looks Undervalued After Its 161% Five Year Run - simplywall.st
ARDX Investors Have Opportunity to Lead Ardelyx, Inc. Securities Fraud Lawsuit with SBS Law - Business Wire
ARDX Stock Is Down Pre-Market After Q4 Earnings Miss, So Why Did This Firm Just Hike Price Target By 80%? - Stocktwits
Ardelyx stock falls 18% after Q2 miss and XPHOZAH target withdrawal - scanx.trade
ARDX SHAREHOLDER ACTION NOTICE: Faruqi & Faruqi, LLP Reminds Ardelyx (NASDAQ: ARDX) Investors of Securities Class Action Lawsuit Deadline on November 16, 2026 - Enidnews.com
ARDX INVESTOR ALERT: Class Action Lawsuit Filed on Behalf - GlobeNewswire
Ardelyx to participate in three major healthcare conferences in September - scanx.trade
Ardelyx Q2FY26 Results: Revenue hits record $118M, IBSRELA guide cut - scanx.trade
Ardelyx Q2 2026 Earnings Call Transcript - benzinga.com
Ardelyx, Inc. (ARDX) Stock Analysis: Unveiling a Potential 281% Upside in the Biotech Sector - DirectorsTalk Interviews
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors It Has Filed a Complaint to Recover Losses Suffered by Purchasers of Ardelyx, Inc. Common Stock and Sets a Lead Plaintiff Deadline of November 16, 2026 - GlobeNewswire
Ardelyx at Morgan Stanley conference: growth plan meets payer pressure By Investing.com - Investing.com South Africa
High Growth Tech Stocks in the US for September 2026 - simplywall.st
ARDX Edges Up After Hours On IBSRELA Momentum And Profitability ‘Right Around The Corner’ - Stocktwits
Ardelyx (ARDX) Could Be 72% Undervalued Following Its September Investor Conference Run - simplywall.st
ARDX Stock Jumps Over 5% Overnight As Director Loads Up In Vote Of Confidence For Flagship Constipation Drug - Stocktwits
Ardelyx at cantor global healthcare conference: growth meets payer pressure - Investing.com
ARDX: Profitability targeted by 2027 as IBSRELA and XPHOZAH drive growth amid payer and market shifts - TradingView
Ardelyx at cantor global healthcare conference: growth meets payer pressure By Investing.com - Investing.com UK
Ardelyx Inc (ARDX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Ardelyx (ARDX) Has Investors Looking Closer, But What Is Driving The Attention? - simplywall.st
Ardelyx CHRO James Brady sells $58,378 in stock By Investing.com - Investing.com Nigeria
Ardelyx CHRO James Brady sells $58,378 in stock - Investing.com
Ardelyx to Participate in Upcoming Investor Conferences - Yahoo Finance
Have Insiders Sold Ardelyx Shares Recently? - simplywall.st
Ardelyx chief patient officer sells $41,419 in stock By Investing.com - Investing.com Australia
Ardelyx chief patient officer sells $41,419 in stock - Investing.com India
Ardelyx CCO Eric Foster sells $33,022 in stock By Investing.com - Investing.com Canada
Ardelyx CCO Eric Foster sells $33,022 in stock - Investing.com India
Ardelyx CBO Mike Kelliher sells $29,921 in shares By Investing.com - Investing.com Canada
Ardelyx CEO Michael Raab sells $225,914 in ARDX stock By Investing.com - Investing.com Canada
Ardelyx chief technical officer John Bishop sells $76,173 in stock By Investing.com - Investing.com Canada
Ardelyx chief human resources officer sells $58,378 in stock By Investing.com - Investing.com Nigeria
Ardelyx chief technical officer John Bishop sells $76,173 in stock - Investing.com India
Ardelyx SVP Joseph Reilly sells $15,358 of company stock By Investing.com - Investing.com Nigeria
Ardelyx SVP Joseph Reilly sells $15,358 of company stock - Investing.com India
Ardelux CFO Susan Hohenleitner sells $6,009 in shares - Investing.com
Ardelyx (ARDX) Cuts Guidance On Payer Hurdles As Fair Value Debate Heats Up - Yahoo Finance
Ardelyx (NASDAQ: ARDX) holder plans tax sale of vesting shares - Stock Titan
Ardelyx (NASDAQ: ARDX) exec plans 10,500-share RSU tax sale - Stock Titan
Ardelyx (NASDAQ: ARDX) insider plans $179K stock sale - Stock Titan
Ardelyx (NASDAQ: ARDX) plans RSU tax-cover sale of 10,500 shares - Stock Titan
Ardelyx (ARDX) exec to sell $18.9K in shares for RSU taxes - Stock Titan
Ardelyx (NASDAQ: ARDX) shareholder John Bishop plans 25,500-share sale - Stock Titan
Ardelyx (NASDAQ: ARDX) officer plans stock sales and tax-cover trades - Stock Titan
Ardelyx (ARDX) officer to sell 11,900 shares for RSU taxes - Stock Titan
0.14%
0.15%
大文字化:
|
ボリューム (24 時間):